CME (CME Group) Stock Analysis - News

CME Group (CME) is a publicly traded Financial Services sector company. As of May 20, 2026, CME trades at $290.34 with a market cap of $110.56B and a P/E ratio of 24.74. CME moved -4.05% today. Year to date, CME is +12.12%; over the trailing twelve months it is +8.79%. Its 52-week range spans $213.94 to $329.16. Analyst consensus is neutral with an average price target of $304.20. Rallies surfaces CME's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in CME news today?

CME Group Flags Hyperliquid’s $21.5B Oil Futures Volume Over KYC-Free Integrity Fears: CME Group and ICE asked the CFTC to probe Hyperliquid’s KYC-free DEX after it processed $21.5 billion in oil perpetual futures, warning of insider trading and price manipulation. The $29 million-funded Hyperliquid Policy Center asserts its on-chain transparency deters misconduct and seeks to work with U.S. regulators on derivatives oversight.

CME Key Metrics

Key financial metrics for CME
MetricValue
Price$290.34
Market Cap$110.56B
P/E Ratio24.74
EPS$11.80
Dividend Yield1.30%
52-Week High$329.16
52-Week Low$213.94
Volume2.06M
Avg Volume0
Revenue (TTM)$6.76B
Net Income$4.27B
Gross Margin0.00%

Latest CME News

Recent CME Insider Trades

  • DUFFY TERRENCE A sold 26.00K (~$7.75M) on May 15, 2026.
  • DUFFY TERRENCE A sold 9.00K (~$2.70M) on May 15, 2026.
  • SHEPARD WILLIAM R bought 1.41K (~$418.65K) on Mar 26, 2026.

CME Analyst Consensus

12 analysts cover CME: 0 strong buy, 4 buy, 5 hold, 3 sell, 0 strong sell. Consensus rating is neutral. Average price target: $304.20.

Common questions about CME

What changed in CME news today?
CME Group Flags Hyperliquid’s $21.5B Oil Futures Volume Over KYC-Free Integrity Fears: CME Group and ICE asked the CFTC to probe Hyperliquid’s KYC-free DEX after it processed $21.5 billion in oil perpetual futures, warning of insider trading and price manipulation. The $29 million-funded Hyperliquid Policy Center asserts its on-chain transparency deters misconduct and seeks to work with U.S. regulators on derivatives oversight.
Does Rallies summarize CME news?
Yes. Rallies summarizes CME news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is CME research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CME. It does not provide personalized investment advice.
CME

CME Group